Faculty profile
Eric Price
Back to facultyThis profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Saskatchewan directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Transition and Post-Transition Radiometals for PET Imaging and Radiotherapy.
Methods in molecular biology (Clifton, N.J.) · 2024 · senior author
Latest funding
- $132,142
Protein Production and Purification Instrumentation for Enzymology, Biocatalysis, and Medicinal Chemistry
NSERC · 2024 · Co-investigator
- $719,100
A theranostic probe targeting the tumor-associated xenoantigen N-Glycoylneuramic acid GM3 ganglioside (Neu5Gc GM3)
CIHR · 2024 · Principal investigator
- $43,000
Synthesis and physicochemical study of new chemical tools towards ideal radiometal- and peptide-based constructs
NSERC · 2024 · Principal investigator
1 publications.
Transition and Post-Transition Radiometals for PET Imaging and Radiotherapy.
Ramogida C, Price E
Protein Production and Purification Instrumentation for Enzymology, Biocatalysis, and Medicinal Chemistry
Principal investigators: Palmer, David
Keywords: biocatalysis; bio-organic chemistry; enzymology; medicinal chemistry; molecular imaging; organic synthesis; protein crystallography; radiochemistry
A theranostic probe targeting the tumor-associated xenoantigen N-Glycoylneuramic acid GM3 ganglioside (Neu5Gc GM3)
Principal investigators: Geyer, Clarence R; Price, Eric W
Keywords: 177-Lutetium; 90-Yttrium; H14f7 Antibody; Neu5gc Gm3; Radio-Immunotherapy; Solid Tumors; Spect-Ct; Theranostic; Xeno-Antigen
Synthesis and physicochemical study of new chemical tools towards ideal radiometal- and peptide-based constructs
Principal investigators: Price, Eric
Keywords: chelators; peptides; zwitterions; unnatural amino acids; radiopharmaceuticals; theranostics; organic synthesis; bioconjugation; coordination chemistry; radiochemistry
Tumor targeted, radiolabeled, mimetic nanovesicle theranostics for imaging and treating head and neck cancer
Principal investigators: Price, Eric W; Geyer, Clarence R
Keywords: Bioconjugation Chemistry; Head And Neck Cancer; Mimetic Nanovesicle; Nanoparticles; Positron Emission Tomography; Radioimmunotherapy; Radionuclide Therapy; Targeted Radionuclide Therapy; Theranostics; Zirconium-89
Radiochemistry
Principal investigators: Price, Eric
New Chelators and Multifunctional Linkers for Enhancing Molecular Imaging Agents: Putting Radiometals into Radiopharmaceuticals
Principal investigators: Price, Eric
Targeting the EphA2 receptor in triple-negative breast cancer
Principal investigators: Freywald, Andrew; Price, Eric W; Vizeacoumar, Franco J
Keywords: Combination Therapy; Epha2; Molecular Imaging Agents; Synthetic Antibody; Synthetic Lethality; Triple-Negative Breast Cancer
Radiochemistry
Principal investigators: Price, Eric
Radiochemistry
Principal investigators: Price, Eric
Radiochemistry
Principal investigators: Price, Eric
Keywords: CRC
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.